Concepedia

Hiroto Ohguchi

HO

Statistics

Publications

34

Citations

2.7K

H-Index

25

Active since

1996

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Tohoku University

Massachusetts General Hospital

The University of Tokyo

Hiroto Ohguchi is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

1996–2024

34

Publications

34

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 431 citations · Full text

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün, Mehmet Samur, Kristen Cowens et al. · Clinical Cancer Research · 2015 · 299 citations · Full text

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

J. Minami, Rikio Suzuki, Ralph Mazitschek et al. · Leukemia · 2013 · 158 citations · Full text

, , +11

Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination

Tadahito Yasuda, Mayu Koiwa, Atsuko Yonemura et al. · Cell Reports · 2021 · 145 citations · Full text

Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma

Teru Hideshima, Jun Qi, Ronald M. Paranal et al. · Proceedings of the National Academy of Sciences · 2016 · 135 citations · Full text

, , +14

1–5 of 34